Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Forward Pharma A/S stock | $6.6

Learn how to easily invest in Forward Pharma A/S stock.

Forward Pharma A/S
- $0.11 ( - 1.67%)

Forward Pharma A/S is a biotechnology business based in the US. Forward Pharma A/S shares (FWP) are listed on the NASDAQ and all prices are listed in US Dollars. Forward Pharma A/S employs 4 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Forward Pharma A/S

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FWP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Forward Pharma A/S stock price (NASDAQ: FWP)

Use our graph to track the performance of FWP stocks over time.

Forward Pharma A/S shares at a glance

Information last updated 2021-10-09.
Latest market close$6.60
52-week range$5.76 - $20.31
50-day moving average $7.02
200-day moving average $7.97
Wall St. target price$37.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.84

Buy Forward Pharma A/S shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Forward Pharma A/S stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Forward Pharma A/S price performance over time

Historical closes compared with the close of $6.6 from 2021-10-14

1 week (2021-10-08) 5.94%
1 month (2021-09-16) 8.20%
3 months (2021-07-16) -40.22%
6 months (2021-04-15) -5.85%
1 year (2020-10-15) 2.17%
2 years (2019-10-15) 570.53%
3 years (2018-10-15) 212.80%
5 years (2016-10-14) 20.2

Is Forward Pharma A/S under- or over-valued?

Valuing Forward Pharma A/S stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Forward Pharma A/S's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Forward Pharma A/S's PEG ratio

Forward Pharma A/S's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.13. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Forward Pharma A/S's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Forward Pharma A/S financials

Gross profit TTM $0
Return on assets TTM -2.62%
Return on equity TTM -6.94%
Profit margin 0%
Book value $10.19
Market capitalisation $43.7 million

TTM: trailing 12 months

Shorting Forward Pharma A/S shares

There are currently 26,503 Forward Pharma A/S shares held short by investors – that's known as Forward Pharma A/S's "short interest". This figure is 16.8% up from 22,688 last month.

There are a few different ways that this level of interest in shorting Forward Pharma A/S shares can be evaluated.

Forward Pharma A/S's "short interest ratio" (SIR)

Forward Pharma A/S's "short interest ratio" (SIR) is the quantity of Forward Pharma A/S shares currently shorted divided by the average quantity of Forward Pharma A/S shares traded daily (recently around 265030). Forward Pharma A/S's SIR currently stands at 0.1. In other words for every 100,000 Forward Pharma A/S shares traded daily on the market, roughly 100 shares are currently held short.

However Forward Pharma A/S's short interest can also be evaluated against the total number of Forward Pharma A/S shares, or, against the total number of tradable Forward Pharma A/S shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Forward Pharma A/S's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Forward Pharma A/S shares in existence, roughly 0 shares are currently held short) or 0.0164% of the tradable shares (for every 100,000 tradable Forward Pharma A/S shares, roughly 16 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Forward Pharma A/S.

Find out more about how you can short Forward Pharma A/S stock.

Forward Pharma A/S share dividends

We're not expecting Forward Pharma A/S to pay a dividend over the next 12 months.

Have Forward Pharma A/S's shares ever split?

Forward Pharma A/S's shares were split on a 1:7 basis on 5 December 2019. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Forward Pharma A/S shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Forward Pharma A/S shares which in turn could have impacted Forward Pharma A/S's share price.

Forward Pharma A/S share price volatility

Over the last 12 months, Forward Pharma A/S's shares have ranged in value from as little as $5.76 up to $20.31. A popular way to gauge a stock's volatility is its "beta".

FWP.US volatility(beta: 1.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Forward Pharma A/S's is 1.7513. This would suggest that Forward Pharma A/S's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Forward Pharma A/S overview

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark. .

Frequently asked questions

What percentage of Forward Pharma A/S is owned by institutions?
Currently 11.37% of Forward Pharma A/S shares are held by institutions.
How many people work for Forward Pharma A/S?
Latest data suggests 4 work at Forward Pharma A/S.
When does the fiscal year end for Forward Pharma A/S?
Forward Pharma A/S's fiscal year ends in December.
Where is Forward Pharma A/S based?
Forward Pharma A/S's address is: Oestergade 24A, Copenhagen, Denmark, 1100
What is Forward Pharma A/S's ISIN number?
Forward Pharma A/S's international securities identification number is: US34986J2042
What is Forward Pharma A/S's CUSIP number?
Forward Pharma A/S's Committee on Uniform Securities Identification Procedures number is: 34986J105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site